Victory Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,317
| Closed | -$463K | – | 2542 |
|
|
2024
Q2 | $463K | Sell |
11,317
-138
| -1% | -$5.64K | ﹤0.01% | 2001 |
|
|
2024
Q1 | $484K | Sell |
11,455
-137
| -1% | -$5.79K | ﹤0.01% | 1992 |
|
|
2023
Q4 | $492K | Buy |
+11,592
| New | +$492K | ﹤0.01% | 2005 |
|
|
2023
Q3 | – | Sell |
-7,377
| Closed | -$235K | – | 2575 |
|
|
2023
Q2 | $235K | Buy |
+7,377
| New | +$235K | ﹤0.01% | 2170 |
|
|
2023
Q1 | – | Sell |
-7,601
| Closed | -$240K | – | 2710 |
|
|
2022
Q4 | $240K | Sell |
7,601
-10,192
| -57% | -$321K | ﹤0.01% | 2224 |
|
|
2022
Q3 | $503K | Sell |
17,793
-1,685
| -9% | -$47.6K | ﹤0.01% | 2054 |
|
|
2022
Q2 | $515K | Buy |
19,478
+1,994
| +11% | +$52.7K | ﹤0.01% | 2040 |
|
|
2022
Q1 | $512K | Buy |
17,484
+9,596
| +122% | +$281K | ﹤0.01% | 2115 |
|
|
2021
Q4 | $256K | Buy |
+7,888
| New | +$256K | ﹤0.01% | 2424 |
|